Linifanib
CAS: 796967-16-3
Ref. TM-T2514
5mg | 51.00 € | ||
10mg | 83.00 € | ||
25mg | 123.00 € | ||
50mg | 184.00 € | ||
100mg | 268.00 € | ||
200mg | 493.00 € | ||
500mg | 802.00 € | ||
1ml*10 (DMSO) | 52.00 € |
Product Information
- ABT-869, RG3635, AL-39324
- Abt 869
- Al 39324
- Linigfanib
- N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea
- Rg 3635
- Urea, N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)-
Linifanib (AL-39324) (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR (IC50: 4 nM), CSF-1R (IC50: 3 nM), Flt-1/3 (IC50: 3/4 nM) and PDGFRβ (IC50: 66 nM). Linifanib may exhibit potent antiproliferative and apoptotic effects on tumor cells whose proliferation is dependent on mutant kinases, such as FMS-related tyrosine kinase receptor-3 (FLT3).
Chemical properties
Technical inquiry about: TM-T2514 Linifanib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.